What’s Behind 300% Jump In Bristol-Myers Squibb’s Cardiovascular Drugs Sales In The Last 4 Years?Forbes • 03/27/20
How Bristol Myers' New MS Drug Has A Leg-Up On A Rival From NovartisInvestors Business Daily • 03/26/20
Bristol Myers Squibb's Multiple Sclerosis Drug, a Potential Blockbuster, Wins FDA ApprovalThe Motley Fool • 03/26/20
3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?The Motley Fool • 03/26/20
Bristol-Myers Squibb's new MS drug is approved, launch delayed due to COVID-19Market Watch • 03/26/20
Will The FDA Approve Bristol's MS Drug? Here Are Some Bullish IndicatorsInvestors Business Daily • 03/25/20
Bristol-Myers Squibb (BMY) Stock Moves -0.8%: What You Should KnowZacks Investment Research • 03/20/20
Bristol Myers Squibb Hints at Further Acquisition Plans With New Executive HireThe Motley Fool • 03/19/20
BMY Stock Dives As Investors Worry Coronavirus Could Delay A Key DrugInvestors Business Daily • 03/16/20